Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-07-27Clinical Trial Update: A Clinical Evaluation Of BW430C (Lamotrigine) In Bipolar I Disorder- Long-term Extension Of Study SCA104779 (NCT00550407) - [Phase 3]
This update reports the long-term extension results of lamotrigine (BW430C) in Bipolar I Disorder from the Phase 3 SCA104779 trial (NCT00550…
-
CLINICAL_TRIALS trial_result · 2011-07-21Clinical Trial Update: Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic Syndrome [Phase 3]
Phase 3 trial comparing aripiprazole with standard of care on non-HDL cholesterol in adults with schizophrenia or bipolar I disorder and met…
-
CLINICAL_TRIALS other · 2011-07-15Clinical Trial Update: Bupropion SR for Major Depression and Depression NOS in Children and Adolescents With Bipolar Disorder [Phase 4]
Phase 4 trial update indicates termination of a study evaluating Bupropion SR for major depressive disorder in children and adolescents with…
-
FDA approval · 2011-07-11FDA Approved: RISPERIDONE — Supplemental Application (Zydus Lifesciences Limited)
FDA approves a supplemental application for Risperidone by Zydus Lifesciences Limited, confirming regulatory approval of changes to the prod…
-
FDA approval · 2011-07-08FDA Approved: SEROQUEL — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for SEROQUEL (quetiapine) submitted by H2-Pharma, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-07-07Clinical Trial Update: Mindfulness-Based Cognitive Behavior Therapy for Bipolar Disorder [NA]
This document reports a completed clinical trial evaluating Mindfulness-Based Cognitive Behavior Therapy for Bipolar Disorder conducted by M…
-
FDA approval · 2011-06-30FDA Approved: RISPERIDONE — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
The FDA approves a supplemental application for generic risperidone by Jubilant Cadista Pharmacuticals Inc., enabling the generic product to…
-
FDA approval · 2011-06-30FDA Approved: RISPERIDONE — Supplemental Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals, LLC's supplemental application for risperidone (RISPERIDONE). This action approves the generic pro…
-
CLINICAL_TRIALS research · 2011-06-28Clinical Trial Update: The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours
A completed AstraZeneca-sponsored study aimed to gain an in-depth understanding of patient management and prescription behaviours in schizop…
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Safety and Efficacy of Olanzapine in the Long-term Treatment for Bipolar I Disorder, Depressed [Phase 3]
This Phase 3 trial update evaluates the long-term safety and efficacy of olanzapine in Bipolar I Disorder with depressive episodes. The stud…
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I Disorder [Phase 3]
A Phase 3 randomized trial comparing topiramate to placebo in bipolar disorder has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: A First Human Dose Study to Investigate Safety and Tolerability of LY2979165 in Healthy Volunteers [Phase 1]
Phase 1 first-in-human study of LY2979165 in healthy volunteers has completed, assessing safety and tolerability.
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: Study of Varenicline (Champix) for Smoking Cessation/Reduction in Patients With Bipolar Disorder [NA]
A completed clinical trial tested varenicline for smoking cessation in patients with bipolar disorder and nicotine dependence.
-
CLINICAL_TRIALS trial_result · 2011-06-22Clinical Trial Update: A Preliminary Study of the Effectiveness and Tolerability of Aripiprazole in Bipolar Depression [Phase 4]
Phase 4 clinical trial evaluating the effectiveness and tolerability of aripiprazole in bipolar depression has completed.
-
FDA approval · 2011-06-21FDA Approved: LAMICTAL XR — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Lamictal XR (lamotrigine) from GlaxoSmithKline LLC. The approval updates the labeling/indication…
-
FDA approval · 2011-06-15FDA Approved: RISPERIDONE — Supplemental Application (Janssen Pharmaceutical, Inc.)
The FDA approved Janssen Pharmaceutical, Inc.'s supplemental application for risperidone, resulting in updated labeling.
-
FDA approval · 2011-06-15FDA Approved: RISPERDAL M-TAB — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for Risperdal M-TAB (risperidone) filed by Janssen Pharmaceuticals, Inc., resulting in an updated/ex…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: A Pharmacokinetic Study of Lithium Before and During Topiramate Dosing in Bipolar Disorder Patients [Phase 1]
A Phase 1 pharmacokinetic study evaluated lithium exposure before and during topiramate dosing in patients with bipolar disorder to assess p…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: A Pharmacokinetic Study of Risperidone and Topiramate Administered Alone and in Combination in Patients With Bipolar Disorder or Schizoaffective Disorders [Phase 1]
A Phase 1 pharmacokinetic study evaluating risperidone and topiramate given alone and in combination in patients with bipolar disorder or sc…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: Functional Remediation for Bipolar Disorder [NA]
The clinical trial 'Functional Remediation for Bipolar Disorder' (NCT01370668) sponsored by Centro de Investigación Biomédica en Red de Salu…
-
CLINICAL_TRIALS trial_result · 2011-06-09Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-release Paliperidone in Subjects With Bipolar I Disorder [Phase 3]
Phase 3 trial evaluating three fixed doses of extended-release paliperidone for bipolar I disorder. The study status is completed.
-
FDA label_change · 2011-06-08FDA Approved: RISPERIDONE — Supplemental Application (Zydus Lifesciences Limited)
FDA records a supplemental application for risperidone by Zydus Lifesciences Limited; specifics of the label changes are not provided in the…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Study to Determine the Effectiveness of Risperidone in Bipolar Disorder in Children and Adolescents [Phase 3]
A Phase 3 clinical trial evaluating risperidone for bipolar disorder in children and adolescents has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder [Phase 3]
A Phase 3 trial evaluating the effectiveness and safety of topiramate for treating bipolar disorder has been completed.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder [Phase 3]
Phase 3 study assessing the safety and efficacy of topiramate for Bipolar I disorder has completed the trial.